Taxol and ionizing radiation: interaction and mechanisms

Area of Science:

• Oncology
• Cell Biology
• Radiation Biology

Background:

• Taxol (paclitaxel) is a clinically active anti-cancer drug.
• Understanding its potential oncogenic effects is crucial for safe clinical application.
• Investigating combined effects with radiation is essential for radiotherapy optimization.

Purpose of the Study:

• To evaluate the in vitro cytotoxic and oncogenic transforming effects of Taxol.
• To assess the combined effects of Taxol and gamma-irradiation on cell transformation.
• To determine Taxol's impact on cell cycle kinetics and radiosensitivity.

Main Methods:

• Mouse C3H 10T1/2 cells were treated with Taxol and/or gamma-irradiation.
• Clonogenic survival and transformation assays were performed post-treatment.
• Cell cycle kinetics were analyzed using bromodeoxyuridine labeling and mitotic cell collection.

Main Results:

• Taxol exhibited dose-dependent cytotoxicity.
• Taxol alone did not induce oncogenic transformation but enhanced gamma-ray-induced transformation supra-additively.
• Taxol partially blocked cells in G2/M phases, increasing their radiosensitivity.

Conclusions:

• Taxol enhances radiation-induced oncogenicity.
• This enhancement is attributed to Taxol's G2/M cell cycle block, sensitizing cells to radiation.
• Findings suggest careful consideration of Taxol's role in radiotherapy when combined with ionizing radiation.